company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,50433000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,50433000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,327000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3767000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-73535000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19008000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19008000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-897000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60156000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69924000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8871000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8871000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-269000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,235000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-34000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-34000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10171000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q3,2010-07-01,2010-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,18000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17239000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17239000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,393000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3801000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,23313000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10268000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10268000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-928000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-91087000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68060000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23955000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23955000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-265000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,771000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,506000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,506000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13181000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,14000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20781000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20781000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,447000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3837000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4266000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20763000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20763000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-860000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-38922000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,77573000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,37791000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,37791000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-251000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,52000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-199000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-199000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16829000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q1,2011-01-01,2011-03-31,2012-05-01 08:00:59+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21474000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21474000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,476000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3200000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,633000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17165000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17165000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-697000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-176007000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69727000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-106977000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-106977000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-234000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,141622000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,141388000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,141388000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,17246000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,17000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17931000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17931000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,506000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3090000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1542000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12793000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12793000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-561000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-97693000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,86756000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11498000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11498000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-181000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,202000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,21000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,21000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24270000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25787000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25787000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,526000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3041000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3566000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18654000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18654000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-185000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-163416000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,181437000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17836000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17836000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-134000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,903000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,769000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,769000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-49000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23174000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23174000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,552000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3098000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3749000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23273000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23273000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1574000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-105926000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,133685000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,26185000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,26185000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,488000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,488000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,488000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3400000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 12:55:50+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24738000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24738000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,610000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3011000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,377000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20740000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20740000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-818000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-118615000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,143406000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23973000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23973000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,885000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,885000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,885000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4118000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25456000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25456000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,635000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3245000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1903000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19625000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19625000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-384000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-58272000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,77735000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19079000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19079000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1196000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1196000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1196000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,650000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25472000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25472000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,636000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3263000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,67000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21554000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21554000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-601000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-192585000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,84898000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-108288000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-108288000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,136525000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,136525000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,136525000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6683000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 13:46:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25574000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25574000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,669000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1793000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1999000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 13:46:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25111000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 13:46:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25111000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-676000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100934000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,127396000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 13:46:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,25786000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 13:46:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,25786000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 13:46:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,675000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22768000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22768000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,628000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1747000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-928000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21321000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21321000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-249000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-108502000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,116959000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8208000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8208000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,822000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,822000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,822000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12291000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23824000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23824000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,644000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2063000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,374000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20743000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20743000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-128000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-66892000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,81926000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14906000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14906000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5837000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16861000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16861000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,651000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1547000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4239000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18902000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18902000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-168000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32518000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,16000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,56166000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23496000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23496000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,229000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,229000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,229000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4823000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22303000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22303000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,655000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2364000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2856000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16428000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16428000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-178000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-79637000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,90275000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10460000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10460000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,24000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,24000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,24000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q1,2014-01-01,2014-03-31,2014-05-07 13:46:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5944000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25391000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25391000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,623000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2132000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2692000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19944000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19944000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-45420000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73750000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,28255000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,28255000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,661000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,661000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,661000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8972000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20942000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20942000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,574000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2080000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-43000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18331000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18331000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46602000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53866000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7258000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7258000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11068000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22272000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22272000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,507000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12415000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5700000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15050000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15050000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-154000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46935000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,234000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,63814000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16959000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16959000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,480000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,480000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,480000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2389000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18193000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18193000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,435000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2054000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,33691000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,17987000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,17987000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-32000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49977000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,59520000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9511000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9511000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,17000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,17000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:22:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27515000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13912000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13912000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,379000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1909000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6522000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18146000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18146000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-73000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32821000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24600000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8294000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8294000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1012000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1012000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1012000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-25428000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6672000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6672000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,287000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1758000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4830000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9457000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9457000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-307000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27084000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,60000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,57977000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30646000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30646000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,98000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,98000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,98000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21287000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12687000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12687000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,338000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1625000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3073000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13797000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13797000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-134000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-41881000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54765000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12750000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12750000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5926000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5926000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5926000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4879000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17464000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17464000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,324000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1438000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6718000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22420000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22420000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-321000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47446000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40996000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6771000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6771000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:22:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-29187000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13533000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13533000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,260000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2014000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7175000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18434000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18434000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-225000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20449000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,39822000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19148000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19148000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9963000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9963000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9963000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10677000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22629000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22629000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,214000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2033000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2189000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22571000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22571000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-252000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14628000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25273000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10393000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10393000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13182000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13182000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13182000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1004000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15590000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15590000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,143000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,115000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2578000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,290000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12464000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12464000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20530000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,88000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22559000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2111000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2111000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2035000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2035000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2035000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8318000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15314000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15314000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,126000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-33000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,718000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6259000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20762000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20762000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-33385000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,732000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32544000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-150000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-150000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,43424000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,43424000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,43424000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q1,2017-01-01,2017-03-31,2018-05-01 16:06:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22512000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19147000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19147000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,114000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-74000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1100000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1463000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19470000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19470000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11535000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19905000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8356000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8356000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3561000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3561000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3561000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7553000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17660000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17660000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,112000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-91000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,873000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-844000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17610000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17610000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-56000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19315000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26932000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7561000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7561000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3337000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3337000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3337000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6712000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25871000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25871000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,113000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-152000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3059000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3136000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19715000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19715000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-53000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-52626000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17439000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35240000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35240000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,67366000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,67366000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,67366000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12411000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24385000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24385000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,113000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-134000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1540000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-528000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23394000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23394000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-197000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5235000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28650000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23218000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23218000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2011000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2011000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2011000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:06:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1835000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25557000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25557000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,159000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-183000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1112000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2525000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26994000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26994000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-684000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36384000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20866000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16202000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16202000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,68149000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,68149000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,68149000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,24953000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23766000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23766000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,159000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-224000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2995000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,754000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20082000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20082000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-156000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8439000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24450000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15855000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15855000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,635000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,635000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,635000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3592000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3228000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3228000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,163000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-225000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2057000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6421000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,11644000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,11644000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-69000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27938000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30100000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2093000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2093000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1099000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1099000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1099000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14836000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17598000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17598000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,164000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-282000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4644000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12503000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-569000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-569000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-377000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19871000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19175000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1073000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1073000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:06:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1626000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20606000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20606000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,173000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-331000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4380000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-267000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16651000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16651000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-115000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-40007000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25450000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14672000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14672000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,856000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,856000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,856000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30467000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11490000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11490000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,166000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-304000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3861000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6874000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14641000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14641000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-352000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-40623000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40681000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-294000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-294000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9789000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9799000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9799000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5136000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17200000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17200000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,180000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-156000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3348000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4179000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9649000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9649000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-611000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-44826000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37820000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7617000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7617000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,694000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,694000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,694000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16572000.0
Rigel Pharmaceuticals Inc,RIGL,,0001034842,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,137000.0
